Comparative Evaluation of Cytotoxicity, Anti-inflammatory, and Drug Release Profiles of Allicin-incorporated GO-AgNP Hydrogel: An In Vitro Study.

Q3 Dentistry
Rathna Piriyanga, Manish Ranjan, Saurav Bathla, Shubhi Gupta, Jai Krishna Srikanth Kolliboyana, Anand Sherwood
{"title":"Comparative Evaluation of Cytotoxicity, Anti-inflammatory, and Drug Release Profiles of Allicin-incorporated GO-AgNP Hydrogel: An <i>In Vitro</i> Study.","authors":"Rathna Piriyanga, Manish Ranjan, Saurav Bathla, Shubhi Gupta, Jai Krishna Srikanth Kolliboyana, Anand Sherwood","doi":"10.5005/jp-journals-10024-3812","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>This study evaluates the cytotoxicity, anti-inflammatory effects, and drug release profiles of an allicin-incorporated graphene oxide-silver nanoparticle (GO-AgNP) hydrogel as an intracanal medicament.</p><p><strong>Materials and methods: </strong>The allicin-incorporated GO-AgNP hydrogel was synthesized and characterized using transmission electron microscopy. Human periodontal ligament (PDL) fibroblasts were used for 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cytotoxicity assays, assessing cell viability at 10, 25, 50, and 100 µg/mL concentrations over 24, 48, and 72 hours. Anti-inflammatory effects were evaluated by analyzing interleukin (IL)-6, IL-8, and tumor necrosis factor (TNF)-α expression in lipopolysaccharide (LPS)-induced RAW 264.7 macrophage cells via quantitative polymerase chain reaction at 24 hours and 7 days. Drug release was assessed using ultraviolet-visible spectrophotometry over 168 hours in root canal-treated teeth.</p><p><strong>Results: </strong>The allicin-incorporated GO-AgNP hydrogel exhibited concentration-dependent cytotoxicity, with cell viability exceeding 90% at 10-20 µg/mL but decreasing significantly at 50-100 µg/mL (<i>p</i> < 0.05). The half-maximal inhibitory concentration was approximately 45 µg/mL. Anti-inflammatory assays showed a reduction in IL-6 (45%), IL-8 (38%), and TNF-α (42%) compared with the LPS-treated control (<i>p</i> < 0.05). Drug release analysis revealed a sustained release pattern, with the 20 µg/mL hydrogel demonstrating a higher cumulative release than the 10 µg/mL hydrogel.</p><p><strong>Conclusion: </strong>The allicin-incorporated GO-AgNP hydrogel demonstrates potential as a biocompatible intracanal medicament with anti-inflammatory properties and controlled drug release. Further optimization is required for clinical application.</p><p><strong>Clinical significance: </strong>This allicin-incorporated GO-AgNP hydrogel shows promise as an intracanal medicament due to its biocompatibility, anti-inflammatory properties, and controlled drug release. By modulating the inflammatory response, it may contribute to reduced postoperative discomfort and improved periapical healing. Additionally, its bioactive properties may support tissue repair and regeneration, making it a potential candidate for regenerative endodontic procedures. How to cite this article: Piriyanga R, Ranjan M, Bathla S, <i>et al.</i> Comparative Evaluation of Cytotoxicity, Anti-inflammatory, and Drug Release Profiles of Allicin-incorporated GO-AgNP Hydrogel: An <i>In Vitro</i> Study. J Contemp Dent Pract 2025;26(1):71-76.</p>","PeriodicalId":35792,"journal":{"name":"Journal of Contemporary Dental Practice","volume":"26 1","pages":"71-76"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Contemporary Dental Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10024-3812","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Dentistry","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: This study evaluates the cytotoxicity, anti-inflammatory effects, and drug release profiles of an allicin-incorporated graphene oxide-silver nanoparticle (GO-AgNP) hydrogel as an intracanal medicament.

Materials and methods: The allicin-incorporated GO-AgNP hydrogel was synthesized and characterized using transmission electron microscopy. Human periodontal ligament (PDL) fibroblasts were used for 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cytotoxicity assays, assessing cell viability at 10, 25, 50, and 100 µg/mL concentrations over 24, 48, and 72 hours. Anti-inflammatory effects were evaluated by analyzing interleukin (IL)-6, IL-8, and tumor necrosis factor (TNF)-α expression in lipopolysaccharide (LPS)-induced RAW 264.7 macrophage cells via quantitative polymerase chain reaction at 24 hours and 7 days. Drug release was assessed using ultraviolet-visible spectrophotometry over 168 hours in root canal-treated teeth.

Results: The allicin-incorporated GO-AgNP hydrogel exhibited concentration-dependent cytotoxicity, with cell viability exceeding 90% at 10-20 µg/mL but decreasing significantly at 50-100 µg/mL (p < 0.05). The half-maximal inhibitory concentration was approximately 45 µg/mL. Anti-inflammatory assays showed a reduction in IL-6 (45%), IL-8 (38%), and TNF-α (42%) compared with the LPS-treated control (p < 0.05). Drug release analysis revealed a sustained release pattern, with the 20 µg/mL hydrogel demonstrating a higher cumulative release than the 10 µg/mL hydrogel.

Conclusion: The allicin-incorporated GO-AgNP hydrogel demonstrates potential as a biocompatible intracanal medicament with anti-inflammatory properties and controlled drug release. Further optimization is required for clinical application.

Clinical significance: This allicin-incorporated GO-AgNP hydrogel shows promise as an intracanal medicament due to its biocompatibility, anti-inflammatory properties, and controlled drug release. By modulating the inflammatory response, it may contribute to reduced postoperative discomfort and improved periapical healing. Additionally, its bioactive properties may support tissue repair and regeneration, making it a potential candidate for regenerative endodontic procedures. How to cite this article: Piriyanga R, Ranjan M, Bathla S, et al. Comparative Evaluation of Cytotoxicity, Anti-inflammatory, and Drug Release Profiles of Allicin-incorporated GO-AgNP Hydrogel: An In Vitro Study. J Contemp Dent Pract 2025;26(1):71-76.

大蒜素掺入的GO-AgNP水凝胶的细胞毒性、抗炎和药物释放的比较评价:一项体外研究
目的:本研究评估了大蒜素-氧化石墨烯-银纳米颗粒(GO-AgNP)水凝胶作为一种肛管内药物的细胞毒性、抗炎作用和药物释放谱。材料与方法:合成蒜素包合的GO-AgNP水凝胶,并用透射电镜对其进行表征。使用人牙周韧带(PDL)成纤维细胞进行3-(4,5-二甲基噻唑-2-基)-2,5-二苯基溴化四唑细胞毒性试验,在10、25、50和100µg/mL浓度下,在24、48和72小时内评估细胞活力。通过定量聚合酶链反应分析脂多糖(LPS)诱导的RAW 264.7巨噬细胞24小时和7天的白细胞介素(IL)-6、IL-8和肿瘤坏死因子(TNF)-α的表达,评价其抗炎作用。采用紫外可见分光光度法测定经根管治疗的牙齿在168小时内的药物释放情况。结果:大蒜素掺入的GO-AgNP水凝胶具有浓度依赖性的细胞毒性,10-20µg/mL时细胞存活率超过90%,50-100µg/mL时细胞存活率显著降低(p < 0.05)。半最大抑制浓度约为45µg/mL。抗炎实验显示,与lps处理的对照组相比,IL-6(45%)、IL-8(38%)和TNF-α(42%)降低(p < 0.05)。药物释放分析显示为缓释模式,20µg/mL水凝胶的累积释放量高于10µg/mL水凝胶。结论:大蒜素掺入的GO-AgNP水凝胶具有抗炎和药物释放控制的生物相容性。临床应用需要进一步优化。临床意义:这种大蒜素掺入的GO-AgNP水凝胶由于其生物相容性、抗炎特性和药物释放控制而显示出作为一种肛管内药物的前景。通过调节炎症反应,它可能有助于减少术后不适和改善根尖周围愈合。此外,其生物活性特性可能支持组织修复和再生,使其成为再生根管治疗的潜在候选者。如何引用本文:Piriyanga R, Ranjan M, Bathla S,等。大蒜素掺入的GO-AgNP水凝胶的细胞毒性、抗炎和药物释放的比较评价:一项体外研究现代医疗实践[J]; 2015;26(1):71-76。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Contemporary Dental Practice
Journal of Contemporary Dental Practice Dentistry-Dentistry (all)
CiteScore
1.80
自引率
0.00%
发文量
174
期刊介绍: The Journal of Contemporary Dental Practice (JCDP), is a peer-reviewed, open access MEDLINE indexed journal. The journal’s full text is available online at http://www.thejcdp.com. The journal allows free access (open access) to its contents. Articles with clinical relevance will be given preference for publication. The Journal publishes original research papers, review articles, rare and novel case reports, and clinical techniques. Manuscripts are invited from all specialties of dentistry i.e., conservative dentistry and endodontics, dentofacial orthopedics and orthodontics, oral medicine and radiology, oral pathology, oral surgery, orodental diseases, pediatric dentistry, implantology, periodontics, clinical aspects of public health dentistry, and prosthodontics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信